Categories: Top News

iTeos annonce ses priorités stratégiques et les étapes importantes attendues en 2024

– Les extractions de données cliniques issues du programme TIGIT attendues en 2024, dont deux essais de Phase II évaluant belrestotug + dostarlimab dans le CPNPC en 1re ligne et le CETC en 1re ligne

Latest posts by GlobeNewswire (see all)
GlobeNewswire

GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Leave a Comment
Share
Published by
GlobeNewswire
Tags: analyst recommendations
1 year ago

Recent Posts

Everbright Digital Holding Limited Announces Closing of Initial Public Offering

HONG KONG, April 21, 2025 (GLOBE NEWSWIRE) -- Everbright Digital Holding Limited (the “Company” or…

17 minutes ago

NorthEast Community Bancorp, Inc. Reports Results for the Three Months Ended March 31, 2025

WHITE PLAINS, N.Y., April 21, 2025 (GLOBE NEWSWIRE) -- NorthEast Community Bancorp, Inc. (Nasdaq: NECB)…

1 hour ago

OWNx Launches Industry-First “EDGE” Membership: Buy Gold, Silver, and Platinum At-Cost with Zero Fees

OWNx, a pioneer in precious metals investment since 2008, today announced the launch of OWNx…

2 hours ago

VitalSource Acquires RedShelf

Raleigh, NC, April 21, 2025 (GLOBE NEWSWIRE) -- VitalSource announced today it has acquired RedShelf,…

2 hours ago

Eurasian Resources Group refutes negotiations to sell the Company

LUXEMBOURG, April 21, 2025 (GLOBE NEWSWIRE) -- In response to a number of media speculations…

2 hours ago

CEYLON GRAPHITE CORP ANNOUNCES PROPOSED SHARE FOR DEBT TRANSACTION

Toronto, April 21, 2025 (GLOBE NEWSWIRE) -- Ceylon Graphite Corp. (TSXV: CYL) (“Ceylon” or the…

3 hours ago

This website uses cookies.